Pharmaceutical News

RSS

Ohio’s drug-pricing ballot question triggers voter confusion

Lawmakers in the nation's capital have yet to grapple with rising drug costs, but Ohio voters are being asked — in a single ballot-box question next week — to figure out how best to lower the tab the state pays for prescriptions.

7 Nov 2017

New study finds enhanced impact of drug combination for FAP patients

People with an inherited syndrome called familial adenomatous polyposis (FAP) have a 100% lifetime risk of developing colorectal cancer if they do not seek appropriate medical care.

7 Nov 2017

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

A popular drug commonly used to treat Alzheimer's disease has shown promise in laboratory and clinical trials for treating patients with sickle cell disease (SCD).

7 Nov 2017

Research examines trend in hospitalizations from opioid poisonings

Preliminary research presented today at APHA's 2017 Annual Meeting and Expo examined the trend in hospitalizations from opioid poisonings in West Virginia, a state heavily impacted by the current opioid overdose crisis.

7 Nov 2017

FDA grants approval to first treatment for rare blood cancer

The U.S. Food and Drug Administration today expanded the approval of Zelboraf (vemurafenib) to include the treatment of certain adult patients with Erdheim-Chester Disease (ECD), a rare cancer of the blood.

7 Nov 2017

Common antidepressants may not work for depressed patients with chronic kidney disease

Scientists are finding more evidence that commonly prescribed antidepressants aren't effective in people battling both depression and a chronic medical disease, raising a critical question of whether doctors should enact widespread changes in how they treat millions of depressed Americans.

7 Nov 2017

FDA approves new drug Zelboraf for Erdheim-Chester disease

The United States Food and Drugs Administration (FDA) has approved Zelboraf (vemurafenib), a drug for the treatment of adults with a are type of blood cancer called Erdheim-Chester Disease or ECD.

6 Nov 2017

Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech

Neem Biotech, the Welsh-based fundamental Research and Development arm of the Zaluvida group of life science companies, was pleased to present the work into development of a novel mode of action as an adjunct to existing antibiotics at the North American Cystic Fibrosis Conference Indiana, USA from 2nd November 2017 to 4th of November 2017.

From Neem Biotech 6 Nov 2017

Biologics do not raise risk of second cancer diagnosis in RA patients

Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting.

6 Nov 2017

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

A recent analysis has linked certain medications commonly used to treat heartburn, acid reflux, and ulcers with the development of kidney disease. The findings will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.

6 Nov 2017

Many patients with knee, hip and spine osteoarthritis use opioids to manage chronic pain

A large percentage of patients with end-stage knee, hip and spine osteoarthritis use opioids to manage their chronic pain, especially those who are younger or have symptoms of depression, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

$Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women$

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Women who took a drug holiday (temporary or permanent discontinuation of a medicine) from using bisphosphonates for more than two years have a significantly higher risk of a hip fracture compared to others who continued their treatment, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

$Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients$

Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients

Opioids and selective serotonin reuptake inhibitors, a widely used group of antidepressants, are both associated with higher risk of osteoporotic fractures for patients with rheumatoid arthritis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Using a biologic therapy to manage rheumatoid arthritis may not significantly increase an infant's risk for developing opportunistic infections like pneumonia, meningitis, and tuberculosis, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.

6 Nov 2017

Researchers develop new drug screening method for rapid, accurate identification of fentanyl

Researchers at McMaster University have developed a new drug screening technique that could lead to the rapid and accurate identification of fentanyl, as well as a vast number of other drugs of abuse, which up until now have been difficult to detect by traditional urine tests.

3 Nov 2017

New research disproves using anti-malaria drug for diabetes treatment

A drug used to treat malaria does not, after all, create new insulin-producing cells, according to a new paper from researchers at the University of California, Davis. The work, published in Cell Metabolism Nov. 2, refutes a study published in Cell in January.

3 Nov 2017

Pharmaceutical News

Ohio’s drug-pricing ballot question triggers voter confusion

New study finds enhanced impact of drug combination for FAP patients

Popular Alzheimer's drug shows promise in clinical trials for treating patients with sickle cell disease

Research examines trend in hospitalizations from opioid poisonings

FDA grants approval to first treatment for rare blood cancer

Common antidepressants may not work for depressed patients with chronic kidney disease

FDA approves new drug Zelboraf for Erdheim-Chester disease

Quorum sensing data presented at the North American Cystic Fibrosis Conference by Neem Biotech

Biologics do not raise risk of second cancer diagnosis in RA patients

Study shows link between use of reflux medications and increased risk of CKD, kidney failure

Many patients with knee, hip and spine osteoarthritis use opioids to manage chronic pain

Drug holiday from bisphosphonates for more than two years linked to higher hip fracture risk in women

Opioid and antidepressant use related to increased risk of osteoporotic fractures for RA patients

Using biologics during pregnancy may not raise infant's risk for opportunistic infections

Researchers develop new drug screening method for rapid, accurate identification of fentanyl

New research disproves using anti-malaria drug for diabetes treatment

Commonly prescribed medications may not benefit depressed CKD patients

Pneuma Respiratory's digital soft mist device can deliver different types of medicines to the lungs

House Republicans aim to yank tax credits for orphan drugs

Combination therapy with azithromycin found to be unnecessary in most children with pneumonia

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News